Mechanism of Platelet Activating Factor-Induced Vascular Leakage in the Rat Trachea

References

• Holtzman M J. Inflammation of the airway epithelium and the development of airway hyperresponsiveness. Prog Respir Res 1985; 19: 165–172
   Google Scholar
• Chung K F, Rogers D F, Barnes P J, Evans T W. The role of increased airway microvascular permeability and plasma exudation in asthma. Eur Respir J 1990; 3: 329–337
   PubMed Web of Science ®Google Scholar
• Barnes P J. Platelet-activating factor and asthma. J Allerg Clin Immunol 1988; 81: 152–160
   PubMed Web of Science ®Google Scholar
• Evans T W, Chung K F, Rogers D F, Barnes P J. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. J Appl Physiol 1987; 63: 479–484
   PubMed Web of Science ®Google Scholar
• Evans T W, Dent G, Rogers D F, Aursudkij B, Chung K F, Barnes P J. Effect of a PAF antagonist, WEB 2086, on airway microvascular leakage in the guinea pig and platelet aggregation in man. Br J Pharmacol 1988; 94: 164–168
   PubMed Web of Science ®Google Scholar
• Sirois M G, Plante G E, Braquet P, Sirois P. Role of eicosanoids in PAF-induced increases of the vascular permeability in rat airways. Br J Pharmacol 1990; 101: 896–900
   PubMed Web of Science ®Google Scholar
• O'Donnell S R, Barnett C JK. Microvascular leakage to platelet activating factor in guinea-pig trachea and bronchi. Eur J Pharmacol 1987; 138: 385–396
   PubMed Web of Science ®Google Scholar
• Block L H, Abraham W M, Groscurth P, Qiao B Y, Perruchoud A P. Platelet-activating factor (PAF)-dependent biochemical, morphologic, and physiologic responses of human platelets: demonstration of translocation of protein kinase C associated with protein phosphorylation. Am J Respir Cell Mol Biol 1989; 1: 277–288
   PubMed Web of Science ®Google Scholar
• Brock T A, Gimbrone M A, Jr. Platelet activating factor alters calcium homeostasis in cultured vascular endothelial cells. Am J Physiol 1986; 250: H1086–H1092
   PubMed Web of Science ®Google Scholar
• Brokaw J J, Hillenbrand C M, White G W, McDonald D M. Mechanism of tachyphylaxis associated with neurogenic plasma extravasation in the rat trachea. Am Rev Respir Dis 1990; 141: 1434–1440
   PubMed Web of Science ®Google Scholar
• Smith L J, Rubin A-H, Patterson R. Mechanism of platelet activating factor-induced bronchoconstriction in humans. Am Rev Respir Dis 1988; 137: 1015–1019
   PubMed Web of Science ®Google Scholar
• Rodrigue F, Hoff P, Touvay C, Vilain B, Carre C, Mencia-Huerta J-M, Braquet P. Platelet-activating factor induces the release of substance P and vascoactive intestinal peptide from guinea pig lung tissues. New Trends Lipid Mediators Res 1988; 2: 93–98
   Google Scholar
• Rogers D F, Boschetto P, Barnes P J. Plasma exudation: correlation between Evans blue dye and radiolabeled albumin in guinea pig airways in vivo. J Pharmacol Methods 1989; 21: 309–315
   PubMedGoogle Scholar
• Brokaw J J, Prow D M, Kirsch C M, White G W. Effects of platelet-activating factor on vascular permeability and granulocyte recruitment in the rat trachea. Lung 1991; 169: 109–119
   PubMed Web of Science ®Google Scholar
• Dent G, Ukena D, Chanez P, Sybrecht G, Barnes P. Characterization of PAF receptors on human neutrophils using the specific antagonist, WEB 2086: correlation between receptor binding and function. FEBS Lett 1989; 244: 365–368
   PubMed Web of Science ®Google Scholar
• Higgs G A, Flower R J, Vane J R. A new approach to anti-inflammatory drugs. Biochem Pharmacol 1979; 28: 1959–1961
   PubMed Web of Science ®Google Scholar
• Lee H K, Murlas C. Ozone-induced bronchial hyperreactivity in guinea pigs is abolished by BW 755C or FPL 55712 but not by indomethacin. Am Rev Respir Dis 1985; 132: 1005–1009
   PubMed Web of Science ®Google Scholar
• Hidaka H, Inagaki M, Kawamoto S, Sasaki Y. Isoquinolinesulfonamides: novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 1984; 23: 5036–5041
   PubMed Web of Science ®Google Scholar
• Joo F, Tosaki A, Olah Z, Koltai M. Inhibition by H-7 of the protein kinase C prevents formation of brain edema in Sprague-Dawley CFY rats. Brain Res 1989; 490: 141–143
   PubMed Web of Science ®Google Scholar
• Hidaka H, Sasaki Y, Tanaka T, Endo T, Ohno S, Fujii Y, Nagata T. TV-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc Natl Acad Sci USA 1981; 78: 4354–4357
   PubMed Web of Science ®Google Scholar
• Barron E, Marshall R J, Martorana M, Winslow E. Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil). Br J Pharmacol 1986; 89: 603–612
   PubMed Web of Science ®Google Scholar
• Reid J L, Meredith P A, Donnelly R, Elliott H L. Pharmacokinetics of calcium antagonists. J Cardiovasc Pharmacol 1988; 12: S22–S26
   PubMed Web of Science ®Google Scholar
• Hsueh W, Gonzalez-Crussi F, Arroyave J L. Platelet-activating factor-induced ischemic bowel necrosis. Am J Pathol 1986; 122: 231–239
   PubMed Web of Science ®Google Scholar
• Paton D M, Webster D R. Clinical pharmacokinetics of H, -receptor antagonists (the antihistamines). Clin Pharmacokinet 1985; 10: 477–497
   PubMed Web of Science ®Google Scholar
• Lipsy R J, Fennerty B, Fagan T C. Clinical review of histamine2 receptor antagonists. Arch Intern Med 1990; 150: 745–751
   PubMed Web of Science ®Google Scholar
• Jancso G, Kiraly E, Jancso-Gabor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature 1977; 270: 741–743
   PubMed Web of Science ®Google Scholar
• Zar J H. Biostatistical Analysis, 2d ed. Prentice-Hall, Englewood Cliffs, NJ 1984
   Google Scholar
• Heymans E, Michel E, Borrel M-C, Wichrowski B, Godfroid J-J, Convert O, Coeffier E, Tence M, Benveniste J. New total synthesis and high resolution :H NMR spectrum of platelet-activating factor, its enantiomer and racemic mixtures. Biochim Biophys Acta 1981; 666: 230–237
   PubMed Web of Science ®Google Scholar
• Tence M, Michel E, Coeffier E, Polonsky J, Godfroid J-J, Benveniste J. Synthesis and biologic activity of some structural analogs of platelet-activating factor (PAF-acether). Agents Actions 1981; 11: 558–559
   PubMedGoogle Scholar
• Wykle R L, Miller C H, Lewis J C, Schmitt J D, Smith J A, Surles J R, Piantadosi C, O'Flaherty J T. Stereospecific activity of 1–0-alkyl-2–0-acetyta”-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils. Biochem Biophys Res Commun 1981; 100: 1651–1658
   PubMed Web of Science ®Google Scholar
• Valone F H, Coles E, Reinhold V R, Goetzl E J. Specific binding of phospholipid platelet-activating factor by human platelets. J Immunol 1982; 129: 1637–1641
   PubMed Web of Science ®Google Scholar
• Hwang S-B, Lee C. SC, Cheah M J, Shen T Y. Specific receptor sites for 1–0-alkyl-2–0-acetyl-sra-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes. Biochemistry 1983; 22: 4756–4763
   PubMed Web of Science ®Google Scholar
• Chung K F, Barnes P J. PAF antagonists. Drugs 1988; 35: 93–103
   PubMed Web of Science ®Google Scholar
• Giembycz M A, Kroegel C, Barnes P J. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. J Immunol 1990; 144: 3489–3497
   PubMed Web of Science ®Google Scholar
• Voelkel N F, Worthen S, Reeves J T, Henson P M, Murphy R C. Nonimmunologi-cal production of leukotrienes induced by platelet-activating factor. Science 1982; 218: 286–288
   PubMed Web of Science ®Google Scholar
• Dahlen S-E, Bjork J, Hedqvist P, Arfors K-E, Hammarstrom S, Lindgren J-A, Samuelsson B. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 1981; 78: 3887–3891
   PubMed Web of Science ®Google Scholar
• Kingston W P, Greaves M W. Actions of prostaglandin E2 metabolites on skin microcirculation. Agents Actions 1985; 16: 13–14
   PubMedGoogle Scholar
• Stewart A G, Dubbin P N, Harris T, Dusting G J. Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells. Proc Natl Acad Sci USA 1990; 87: 3215–3219
   PubMed Web of Science ®Google Scholar
• Swingle K F, Reiter M J. Inhibition of PAF-acether-induced edema of the rat's paw. Agents Actions 1986; 18: 359–365
   PubMedGoogle Scholar
• Struhar D, Harbeck R J. Inhibition of induced acute lung edema by a novel protein kinase C inhibitor. FASEB J 1987; 1: 116–118
   PubMed Web of Science ®Google Scholar
• Rasmussen H. Calcium and cAMP in stimulus-response coupling. Ann NY Acad Sci 1980; 356: 346–353
   PubMedGoogle Scholar
• Weiss B, Prozialeck W, Cimino M, Barnett M S, Wallace T L. Pharmacological regulation of calmodulin. Ann NY Acad Sci 1980; 356: 319–345
   PubMedGoogle Scholar
• Levy J V. Calmodulin antagonists inhibit aggregation of human, guinea pig and rabbit platelets induced with platelet activating factor. FEBS Lett 1983; 154: 262–264
   PubMed Web of Science ®Google Scholar